{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": {
    "pdf_name": "Treanor_et_al.__2011_",
    "source_pdf": "data/clinical_files/Treanor et al. (2011).pdf",
    "total_pages": 7,
    "total_blocks": 97,
    "total_characters": 28697
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 3,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "The vaccine (Flublok used in this study consisted of puri- ed hemagglutinin (HA) proteins produced in insect cells using baculo virus expression system as previously described [9].",
      "relevance_explanation": "This quote directly states that Flublok is produced by expressing hemagglutinin (HA) proteins in insect cells using a baculovirus expression system, which matches the claim about the novel production platform."
    },
    {
      "id": 2,
      "quote": "Genes were cloned into baculo virus using RT-PCR from the same CDC- eri ved vaccine seed viruses used for the production of licensed nactivated influenza vaccine for that year.",
      "relevance_explanation": "This quote provides evidence that the production process involves cloning genes into baculovirus, which is a key step in the baculovirus expression vector system (BEVS) described in the claim."
    },
    {
      "id": 3,
      "quote": "Expression of proteins in insect cells using recombinant baculo virus expression system has been shown to be a promising alternative to egg-based vaccine production.",
      "relevance_explanation": "This quote affirms that the production platform for Flublok involves expressing proteins in insect cells using a recombinant baculovirus system, supporting the claim of a novel BEVS-based platform."
    }
  ],
  "model_used": "gpt-4.1"
}